Core Insights - Pandora is expected to achieve organic growth of 6% for 2025, slightly below the previous guidance of 7-8% [1] - The group EBIT margin for 2025 is anticipated to align with guidance at approximately 24% [1] - The audited full-year results for 2025 will be announced on February 5, 2026 [1] Financial Performance - Q4 2025 revenue was DKK 11.9 billion, a slight decrease from DKK 12.0 billion in Q4 2024 [5] - FY 2025 revenue is projected at DKK 32.5 billion, up from DKK 31.7 billion in 2024 [5] - Q4 2025 organic growth was 4%, compared to 11% in Q4 2024 [5] - Like-for-like growth was flat at 0% in Q4 2025, down from 6% in Q4 2024 [5] - Q4 2025 EBIT margin is expected to be around 33.5%, down from 34.7% in Q4 2024 [5] Market Conditions - The overall performance reflects weak consumer sentiment, particularly in North America during Q4 2025 [2] - North America reported 2% like-for-like growth in Q4 2025, with trading in November and December falling below expectations [8] - EMEA region experienced a -1% like-for-like growth, with strong performance in Spain, Poland, and Portugal offset by weakness in Italy [8] - Asia-Pacific and Latin America reported like-for-like growth of 2% and -7%, respectively [8] Leadership and Strategy - Berta de Pablos-Barbier was appointed as President & CEO of Pandora on January 1, 2026 [3] - The new CEO will outline strategic priorities for 2026, focusing on reducing commodity exposure and enhancing brand desirability [3][5] - The company aims to leverage untapped growth opportunities as a full jewellery brand [5] Gross Margin and Cost Control - Q4 2025 gross margin is expected to be around 78%, reflecting strong cost discipline [8] - The company anticipates FY 2025 EBIT to be approximately DKK 7.8 billion [8]

Core Viewpoint - Guggenheim maintains a Buy rating and a $125 price target on Dollar General, indicating confidence in the stock's future performance despite its recent outperformance [1]. Group 1: Stock Performance and Valuation - Dollar General shares have significantly outperformed this year, driven by EBIT recovery linked to lower shrink expenses, yet the stock is still trading at a reasonable 8.2x Guggenheim's 2026E EBITDA estimate [2]. - The firm believes that upcoming developments, such as potentially strong third-quarter results and a raised full-year outlook, will support further upside [2]. Group 2: Earnings Expectations and Challenges - Guggenheim views Street expectations for 2026 earnings as conservative, especially with the potential for easing LIFO and interest expenses, as well as a reduced share count, even with a mostly flat EBIT margin [3]. - The firm recognizes challenges in achieving Dollar General's long-term EBIT margin target of 6%–7%, particularly after shrink normalizes in the first half of 2026 [3]. - Despite these challenges, Guggenheim retains its Buy rating until near-term catalysts are fully realized [3].

Core Viewpoint - Evercore ISI has lowered its price target for BJ's Wholesale Club Holdings to $85 from $100, maintaining an In Line rating due to near-term margin pressures and slowing comparable-store sales [1] Financial Estimates - FY2025 EPS estimate has been cut to $4.25 and FY2026 EPS to $4.65, with expectations of modest price and wage investments to support market share and inventory turnover [2] - Q3 comparable sales growth is forecasted to be below 2%, compared to Street estimates of 2.5%, with EPS expected at $1.07, slightly below the consensus of $1.10 [3] Margin and Profitability - A 60-basis-point decline in gross margin is modeled as BJ's invests in pricing to strengthen member loyalty, while fuel mix and penny profit pressures weigh on profitability [3] - EBIT margin is forecasted at 4%, down 60 bps year over year, with EBIT expected to be $210 million, representing a 9% decline compared to the prior year [3] Future Guidance - Management is likely to guide for a 1–2% comparable sales growth in the fourth quarter, implying EPS of $0.88–$0.92 versus Street estimates of $0.94 [4] Executive Changes - Recent executive changes, including the departure of Chief Merchant Rachel Vegas to Walgreens, may indicate challenges in BJ's merchandising strategy [5] - Despite improvements in general merchandise offerings, comparable sales in the 2–3% range suggest market share softness relative to expectations for steady 3–4% growth and operating margin expansion [5]

This story was originally published on WardsAuto. To receive daily news and insights, subscribe to our free daily WardsAuto newsletter. Jaguar Land Rover reported a 24% hit to its second quarter results ending Sept. 30, 2025 (Q2 FY26), blaming a cyberattack that shuttered global vehicle production in September and the impact of U.S. tariffs. Its results showed Q2 revenues of £4.9 billion ($6.44 billion), while first half year revenues were £11.5 billion, down 16% YoY due to production stoppages and the p ...

Core Viewpoint - Erste Group downgraded Advanced Micro Devices (AMD) from Buy to Hold, resulting in a 2% decline in shares during Thursday's session [1] Group 1: Company Performance - AMD is expected to see growth in 2025 due to increasing demand for high-performance CPUs and GPUs in data centers [1] - Operating margins for AMD remain below sector averages, with EBIT margin reported as slightly negative in the most recent quarter [1] - AMD's return on equity is weaker than its peers, leading to a perception that the current valuation is elevated [1]

Core Viewpoint - Trian Fund Management commends Solventum Corporation for the sale of its Purification & Filtration business to Thermo Fisher Scientific, viewing it as a significant step in the company's value creation journey [1][2] Group 1: Sale Details - Solventum's Purification & Filtration business was sold to Thermo Fisher Scientific, with Trian noting the high valuation multiple attracted by the division's differentiated technology and material science [1] - Thermo Fisher anticipates that the acquisition will be accretive by $0.28, indicating strong cost synergies from replacing Solventum's allocated segment costs with lower costs within Thermo Fisher [2] Group 2: Financial Performance and Growth Potential - Trian highlighted that Solventum has the opportunity to right-size costs and achieve higher margins while reinvesting in growth [3] - Historically, while part of 3M, Solventum achieved 3-4% organic growth and a 26-27% EBIT margin, and Trian believes that as a standalone company, Solventum can deliver faster organic growth and higher margins [4]